Sign Up Today and Learn More About SOMAĆ Pharmaceuticals Stock
Invest in or calculate the value of your shares in SOMAĆ Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
![SOMAĆ Pharmaceuticals](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/somaipharma_logo-8f226b1af12de529.png)
SOMAĆ Pharmaceuticals Stock
SOMAĆ Pharmaceuticals is a pharmaceutical and biotech company that specializes in cannabinoid-containing pharmaceutical medicines.
About SOMAĆ Pharmaceuticals Stock
Founded
2019
Industries
Software, Data and Analytics, Artificial Intelligence
SOMAĆ Pharmaceuticals Press Mentions
Stay in the know about the latest news on SOMAĆ Pharmaceuticals
European Cannabis Q1 2024 Quarterly Update
talkmarkets ā¢ Aug 22, 2024
What is Spainās New Medical Cannabis Regulatory Framework?
legalreader ā¢ Aug 21, 2024
Interview mit Michael Sassano, CEO von SOMAĆ Pharmaceuticals
hanfjournal ā¢ Aug 21, 2024
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAĆ Group for Global Distribution
newswire ā¢ Aug 04, 2024
Pila Pharma - Aktiedagarna Stockholm 12 juni 2024
linkedin ā¢ Aug 04, 2024
SOMAĆ Pharmaceuticals Management
Leadership team at SOMAĆ Pharmaceuticals
Chief Operating Officer and Co-Founder
George Bellow
Founder, Chairman and CEO
Michael Sassano
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- SOMAĆ Pharmaceuticals current valuation
- SOMAĆ Pharmaceuticals stock price
- Available deals in SOMAĆ Pharmaceuticals and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in SOMAĆ Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like SOMAĆ Pharmaceuticals through EquityZen funds. These investments are made available by existing SOMAĆ Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event ā house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SOMAĆ Pharmaceuticals stock?
Shareholders can sell their SOMAĆ Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."